Grants per year
Search results
-
Active
Prot #1425-0003: A Phase IIa, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BI 706321 Orally Administered for 12 Weeks in Patients with Crohn`s Disease (CD) Receiving Ustekinu
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.
1/17/24 → 1/17/27
Project: Research project
-
Prot #IM047029: A Phase 4, Prospective, Open‐label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clinical Practice
Hanauer, S. B. (PD/PI)
PPD Investigator Services, LLC, Celgene International II Sàrl
9/25/23 → 9/25/26
Project: Research project
-
: Prot #78934804CRD2001: A Phase 2b Randomized, Double‐blind, Active‐ and Placebo‐controlled, Parallel‐ group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Partici
Hanauer, S. B. (PD/PI)
Parexel, Janssen Research & Development, LLC
6/12/23 → 8/24/28
Project: Research project
-
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
Bonner, L. B. (PD/PI), Bonner, L. B. (PD/PI), Dulai, P. S. (PD/PI), Dulai, P. S. (PD/PI), Hanauer, S. B. (Co-Investigator), Hanauer, S. B. (Co-Investigator), Hanauer, S. B. (Co-Investigator), Hirano, I. (Co-Investigator), Hirano, I. (Co-Investigator), Scholtens, D. M. (Co-Investigator), Scholtens, D. M. (Co-Investigator), Sumagin, R. (Co-Investigator), Sumagin, R. (Co-Investigator), Sumagin, R. (Co-Investigator), Yang, G.-Y. (Co-Investigator), Yang, G.-Y. (Co-Investigator) & Yang, G.-Y. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
3/15/23 → 2/29/28
Project: Research project
-
Prot #RCT01437: Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: The OPTIMIZE Trial
Hanauer, S. B. (PD/PI) & Hanauer, S. B. (PD/PI)
Beth Israel Deaconess Medical Center, Leona M. and Harry B. Helmsley Charitable Trust
3/1/21 → 2/28/26
Project: Research project
-
GS-US-419-3896: A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn’s Disease
Hanauer, S. B. (PD/PI)
PRA Health Sciences, Gilead Sciences, Inc
1/17/18 → 1/31/25
Project: Research project